Saturday - August 16, 2025
Covington Represents IGI Therapeutics in Exclusive Global Licensing Agreement With AbbVie
July 11, 2025
NEW YORK, July 11 -- Covington, a law firm, issued the following news release:

* * *

Covington Represents IGI Therapeutics in Exclusive Global Licensing Agreement with AbbVie

Covington represented IGI Therapeutics SA, a wholly owned subsidiary of New York-based Ichnos Glenmark Innovation, Inc. (IGI), in an exclusive licensing agreement with AbbVie for IGI's lead investigational asset, ISB 2001, developed using IGI's proprietary BEAT(R) protein pla . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation		 Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products